Managing diabetes with nanomedicine: challenges and opportunities - Wikidata - wikimedia - TriplyDB

Managing diabetes with nanomedicine: challenges and opportunities

Managing diabetes with nanomedicine: challenges and opportunities

http://www.wikidata.org/entity/Q36574654

about

Nanomedicine concepts in the general medical curriculum: initiating a discussion Smart nanosystems: Bio-inspired technologies that interact with the host environment Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid-Glucose Complexation A Robust, Enzyme-Free Glucose Sensor Based on Lysine-Assisted CuO Nanostructures Implantable batteryless device for on-demand and pulsatile insulin administration Culture of iPSCs Derived Pancreatic β-Like Cells In Vitro Using Decellularized Pancreatic Scaffolds: A Preliminary Trial Smart approaches to glucose-responsive drug delivery Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery A Nanoparticle-Decorated Biomolecule-Responsive Polymer Enables Robust Signaling Cascade for Biosensing.Gmelina arborea Roxb. (Family: Verbenaceae) Extract Upregulates the β-Cell Regeneration in STZ Induced Diabetic Rats Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression.Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery.Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.Light Control of Insulin Release and Blood Glucose Using an Injectable Photoactivated Depot.Mechanism of hard-nanomaterial clearance by the liver.Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.Coating nanoparticles with cell membranes for targeted drug delivery.Nanotechnology for protein delivery: Overview and perspectives.Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Yeast capsules for targeted delivery: the future of nanotherapy?Economic 3D-printing approach for transplantation of human stem cell-derived β-like cells.Simultaneous expression and transportation of insulin by supramolecular polysaccharide nanocluster.Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.Nanomedicines for dysfunctional macrophage-associated diseases.Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria.Bioresponsive transcutaneous patches.Microfluidic-assisted fabrication of carriers for controlled drug delivery.Conjugated polymer nanomaterials for theranostics.Cross-Linked Dependency of Boronic Acid-Conjugated Chitosan Nanoparticles by Diols for Sustained Insulin Release.H2O2-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery Spherulitic copper-copper oxide nanostructure-based highly sensitive nonenzymatic glucose sensor.Biogenic synthesis of Marsilea quadrifolia gold nanoparticles: a study of improved glucose utilization efficiency on 3T3-L1 adipocytes.Glucose-Responsive Insulin Delivery by Microneedle-Array Patches Loaded with Hypoxia-Sensitive Vesicles.Red Blood Cells for Glucose-Responsive Insulin Delivery.Insulin-Responsive Glucagon Delivery for Prevention of Hypoglycemia.Glucose-responsive insulin by molecular and physical design.Synthetic beta cells for fusion-mediated dynamic insulin secretion.Advances in bioresponsive closed-loop drug delivery systems.

P2860

Q26775137-B6F39F01-EB69-4700-AC86-2505C34DD052 Q26776370-3B13FB6F-F366-4B4B-863C-84D9F8660A73 Q28468535-9DD35757-57D6-4684-BB11-5BCB49F2DC6C Q28818066-ADF588EE-4460-4943-816D-6961A9232852 Q30846603-F57E130F-27A5-4552-A81F-E0E015F127A5 Q33578664-8EFB4004-756D-46F7-BE5C-FE120D1857F2 Q33742934-90836B6A-8E76-4B94-93D5-90486E27539A Q34045963-7C95142C-B4F9-4656-8AD6-6E52DD9A9FBC Q34481917-DC0E4158-C8C5-40AE-9D7D-2E72DF3864DD Q36404993-80E30FC7-17F0-40DE-8B79-CB5A9C929B0C Q36531530-BF65533F-CD64-46B4-A437-41578719EB6D Q37115002-B17B41AC-27A1-4673-8F0C-2FD253DDF007 Q37206883-4E5B5A1E-8C1C-4C39-875A-285457C70C28 Q37207691-DCF6610C-1B52-4A51-846C-A929819B78BC Q37402667-EFDB40F7-D6A1-4F4A-841D-967B818032B9 Q37462904-A11B219E-576D-4CE8-B9EB-00C3DBFDE988 Q37575966-462631A0-B19A-495E-AE9C-8791EC6F2046 Q38603358-1F3DBC96-3293-4133-9C29-0C0A8EC1989A Q38605185-2BFD90FC-3076-4791-8A2A-DB1D0F584626 Q38616795-411BF16F-AA44-43D4-AE33-B12F3DB0D70F Q38645059-422DAAAF-A42C-47AA-B386-9794D7A0115E Q38691189-4CAAC04E-D212-4716-BA54-BC8A0FB65112 Q38788587-BEF8E66D-BA19-4F1F-9BDB-06688415B65C Q38805344-CA520837-6886-435D-A3E7-4F33B6A95510 Q38828033-464EC8D9-27BF-4D82-A80F-BD409D116581 Q39069052-225CD8A1-D23B-447B-B18B-4BC9719D7097 Q39118683-DD62EE6F-DCFB-4AD8-92CE-85693B4AB2B9 Q39178278-59710AFE-0D20-447D-B5DC-CA0AB27A2022 Q39289983-7EE90578-1685-472C-A547-EFEA938F9EDA Q39335439-55B13397-93E8-4389-BF43-E68D0B8755CD Q40242838-C58CD9F4-F9B6-4D17-973A-BF763DE7AB69 Q41501957-138BA541-56D0-402C-84BA-5D785648A8FE Q42580495-679BFECD-3DAA-4B41-9DCE-20C986653ECF Q42801715-22F4E085-A472-49AC-9220-8A9468D09190 Q44870456-8DC14A6B-2576-4927-A06A-D86C2322919F Q44870674-6CCB4030-24CA-4F8E-A2DE-76F7F89C28FC Q44871115-A8AE5ABA-777B-471B-8012-005EDE182261 Q44875590-702B813B-4681-4F61-833B-9CC35E1DCE7B Q44876627-CD3E0E74-7EE6-4EDE-A92C-9EB4D93AF00F Q44877496-45906784-CD07-4582-BA2C-D984A085CE11

P2860

Managing diabetes with nanomedicine: challenges and opportunities

http://www.wikidata.org/entity/Q36574654

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Managing diabetes with nanomedicine: challenges and opportunities

@ast

Managing diabetes with nanomedicine: challenges and opportunities

@en

type

label

Managing diabetes with nanomedicine: challenges and opportunities

@ast

Managing diabetes with nanomedicine: challenges and opportunities

@en

prefLabel

Managing diabetes with nanomedicine: challenges and opportunities

@ast

Managing diabetes with nanomedicine: challenges and opportunities

@en

P1433

Q36574654-EA87FF80-F174-4EE1-856D-0B0DAF4D5453

P1476

Q36574654-A86B5815-0AF1-44B7-8633-EF61805BAA5F

P2093

Q36574654-3FE65BE7-846D-48AA-A99A-F6D5BAF4F284

Q36574654-6559D556-488B-47DB-ABDD-24DB1A9F71F4

Q36574654-BC77BCB0-2B70-46F1-AD2C-73426C27F599

Q36574654-FD28F983-25EB-4DBC-9DCF-3BF9B7923AC4

P2860

Q36574654-007522C6-5B41-48D7-B3DA-373BAB8BCC5E

Q36574654-0395D09B-9409-4307-A897-462A32EA7F6B

Q36574654-04172396-3CDA-4711-93D3-C8677E03EE88

Q36574654-06909FD4-2776-4FA2-A033-16D31074E645

Q36574654-0702417E-FBC3-4307-BDDD-B8CD551F3B14

Q36574654-0A55162C-D6C3-4755-9FC4-E47A8354F6EC

Q36574654-0AC14B50-BAB1-4795-B76E-274E78D61203

Q36574654-0C46C20C-6414-4C6B-974A-7C4F7177893D

Q36574654-0EC84C35-A854-47DB-8982-5F9107C67283

Q36574654-0FA0B720-065B-40F1-A352-61FB6DAB0952

P2888

Q36574654-5ABC63B1-740B-4659-A555-4BEB9FA13D81

P304

Q36574654-38CC4D0C-210F-4AAD-856F-FFB78D454278

P31

Q36574654-E2059DCC-CFF0-4624-88DA-5A16A5D754B1

P356

Q36574654-6B76A448-9AF9-4996-A117-A47C28D01081

P433

Q36574654-4A30B107-2237-428A-9B0F-16F25ADA925A

P478

Q36574654-E744DDA1-BDCB-4C15-A488-E3889999C8E8

P50

Q36574654-06BE9AF4-84B8-47D3-9045-C8D1DA2A53F4

P577

Q36574654-0E0C6A4D-0207-49C3-8855-590CC69310DE

P698

Q36574654-990B0E4C-DEEE-4C95-84B5-CB49EC5A3F86

P932

Q36574654-7B49BEF6-BF43-456E-A8BB-1F046D8AB7F8

P356

P1433

Nature Reviews Drug Discovery

P1476

Managing diabetes with nanomedicine: challenges and opportunities

@en

P2093

Benjamin C Tang

http://www.w3.org/2001/XMLSchema#string

Daniel G Anderson

http://www.w3.org/2001/XMLSchema#string

Kathryn A Whitehead

http://www.w3.org/2001/XMLSchema#string

Omid Veiseh

http://www.w3.org/2001/XMLSchema#string

P2860

RETRACTED: Betatrophin: a hormone that controls pancreatic β cell proliferation

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Imaging in the era of molecular oncology.

Safe clinical use of carbon nanotubes as innovative biomaterials

Encapsulated islet transplantation: strategies and clinical trials

Islet transplantation as a treatment for diabetes - a work in progress

Percutaneous fiber-optic sensor for chronic glucose monitoring in vivo

Standards of medical care in diabetes--2014

Global estimates of the prevalence of diabetes for 2010 and 2030

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

P2888

P304

45-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRD4477

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Robert Samuel Langer, Jr.

P577

2014-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25430866

http://www.w3.org/2001/XMLSchema#string

P932

4751590

http://www.w3.org/2001/XMLSchema#string